AcrySof®
ReSTOR® IOL
AcrySof®
ReSTOR® is
a breakthrough lens that uses apodized
diffractive technology to give patients a
full range of vision- near through distance-
and greatly reduces their reliance on
reading glasses or bifocals. The AcrySof®
ReSTOR®
intraocular lens (IOL) is an artificial lens
used in cataract surgery for patients with
and without
presbyopia. The unique patented
optic design results in highly-predictable
visual acuity results, meaning patients can
read the font on items such as prescription
bottles, magazines, newspapers and computer
screens, while also providing the ability to
see items at a distance independent of
reading glasses or bifocals. In fact,
clinical trials have demonstrated that four
out of five patients never needed to wear
glasses or bifocals following bilateral
cataract surgery.
Clinical data demonstrates that AcrySof®
ReSTOR® IOL
greatly reduces dependence on glasses or
bifocals. 80 percent of patients in the FDA
clinical study did not need to wear glasses
with AcrySof®
ReSTOR® IOL,
compared to eight percent in the monofocal
control group following bilateral cataract
surgery.
Combined Visual Acuity: 84.3 percent of
patients demonstrated combined uncorrected
vision without glasses of 20/25 or better
for distance and 20/32 or better for near.
85 percent of AcrySof®
ReSTOR®
patients achieved 20/40 or better binocular
uncorrected intermediate vision.
In
most states, 20/40 vision allows individuals
to pass the visual requirements for the
driver’s license test without glasses or
contact lenses.
The AcrySof®
ReSTOR® IOL
is made of the same highly-biocompatible
acrylic material as Alcon’s market-leading
AcrySof®
family of intraocular lenses, which have
been implanted in more than 21 million human
eyes since 1991.
AcrySof®
ReSTOR® IOL
uses a combination of three complementary
technologies: apodization, diffraction and
refraction. Its unique apodized diffractive
optic design provides the ability to focus
light correctly on the
retina for images at
various distances without mechanical
movement of the lens.
Apodization
is a gradual reduction or blending of the
diffractive step heights.
This unique technology optimally manages
light energy delivered to the retina because
it distributes the appropriate amount of
light to near and distant focal points,
regardless of the lighting situation.
Apodized diffractive optics are designed
to improve image quality while minimizing
visual disturbances. The result is an
increased range of quality vision that
delivers a high level of spectacle freedom.
The AcrySof®
ReSTOR® IOL
achieved CE mark status April 4, 2003, and
is currently being implanted in patients
outside the U.S. AcrySof®
ReSTOR® IOL
received FDA approval on March 21, 2005.
|